1. Home
  2. PJT vs ADMA Comparison

PJT vs ADMA Comparison

Compare PJT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$130.27

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$14.89

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PJT
ADMA
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
PJT
ADMA
Price
$130.27
$14.89
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$179.50
$32.00
AVG Volume (30 Days)
320.2K
3.3M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.60
Revenue
$1,713,671,000.00
$42,219,783.00
Revenue This Year
$11.47
$27.46
Revenue Next Year
$10.27
$21.11
P/E Ratio
$23.03
$24.71
Revenue Growth
14.77
43.85
52 Week Low
$119.76
$13.76
52 Week High
$195.62
$25.67

Technical Indicators

Market Signals
Indicator
PJT
ADMA
Relative Strength Index (RSI) 24.93 40.08
Support Level N/A $14.19
Resistance Level $186.13 $15.84
Average True Range (ATR) 4.72 0.77
MACD -0.69 0.01
Stochastic Oscillator 10.71 10.54

Price Performance

Historical Comparison
PJT
ADMA

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: